首页> 外文期刊>Stem cells translational medicine. >Proceedings: Moving Toward Cell-Based Therapies for Liver Disease
【24h】

Proceedings: Moving Toward Cell-Based Therapies for Liver Disease

机译:论文集:转向基于细胞的肝病治疗

获取原文
           

摘要

Despite available medical therapy and organ transplantation, a significant unmet medical need remains for the treatment of liver failure, end-stage liver disease, and liver-based inborn errors of metabolism. Liver cell transplantation has the potential to address this need; however, the field is in search of a suitable cell therapeutic. The ability to reproducibly generate a well-characterized source of engraftable and functional liver cells has continued to be a challenge. Recent progress with tissue-derived stem/progenitor cells and pluripotent stem cell-derived cells now offers the field the opportunity to address this challenge.
机译:尽管有可用的药物治疗和器官移植,但是仍然存在用于治疗肝衰竭,终末期肝病和基于肝脏的先天性代谢错误的仍未满足的重要医疗需求。肝细胞移植有可能满足这一需求。然而,该领域正在寻找合适的细胞治疗剂。可再现地产生可移植的和功能性肝细胞特征充分的能力一直是一个挑战。组织来源的干/祖细胞和多能干细胞来源的细胞的最新进展为该领域提供了应对这一挑战的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号